Viewing Study NCT00151450


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2025-12-31 @ 9:33 PM
Study NCT ID: NCT00151450
Status: COMPLETED
Last Update Posted: 2021-01-22
First Post: 2005-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module